Abstract The fulminant viral myocarditis is associated to a high risk of mortality and heart transplantation in children. Anti-inflammatories and intravenous gamma globulin are used in the majority of studies… Click to show full abstract
Abstract The fulminant viral myocarditis is associated to a high risk of mortality and heart transplantation in children. Anti-inflammatories and intravenous gamma globulin are used in the majority of studies but the outcome is not always favorable. In this case, we suggest an important role for antiviral therapy in children's fulminant myocarditis.
               
Click one of the above tabs to view related content.